# Midodrine for the Early Liberation of Vasopressor Support in the ICU

> **NCT04489589** · PHASE4 · COMPLETED · sponsor: **University of Alberta** · enrollment: 20 (actual)

## Conditions studied

- Critical Illness
- Shock

## Interventions

- **DRUG:** Midodrine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04489589
- **Lead sponsor:** University of Alberta
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-03-22
- **Primary completion:** 2022-07-31
- **Final completion:** 2022-10-30
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2023-10-06

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04489589

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04489589, "Midodrine for the Early Liberation of Vasopressor Support in the ICU". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT04489589. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*